SunTrust Downgrades Tetraphase Pharmaceuticals (TTPH) to Neutral
Tweet
Share
E-mailGet Alerts TTPH Hot Sheet
Price: $2.20 --0%
Rating Summary:
6 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 17 | New: 43
Rating Summary:
6 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 17 | New: 43
Join SI Premium – FREE
SunTrust Robinson Humphrey downgraded Tetraphase Pharmaceuticals (NASDAQ: TTPH) from Buy to Neutral with a price target of $12.00 (from $54.00).
For an analyst ratings summary and ratings history on Tetraphase Pharmaceuticals click here. For more ratings news on Tetraphase Pharmaceuticals click here.
Shares of Tetraphase Pharmaceuticals closed at $44.78 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla (TSLA) PT Raised to $500 at RBC Capital on 'Potential SpaceX Combination'
- H&H International Holdings (1112:HK) (BTSDF) PT Raised to HK$20.90 at Citi
- Berkeley Group Holdings Plc. (BKG:LN) (BKGFF) PT Lowered to GBP45.17 at Jefferies
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
SunTrust Robinson HumphreySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
